US20060095023A1 - Time-resolved scanning patterns for intrastromal surgery - Google Patents
Time-resolved scanning patterns for intrastromal surgery Download PDFInfo
- Publication number
- US20060095023A1 US20060095023A1 US10/978,613 US97861304A US2006095023A1 US 20060095023 A1 US20060095023 A1 US 20060095023A1 US 97861304 A US97861304 A US 97861304A US 2006095023 A1 US2006095023 A1 US 2006095023A1
- Authority
- US
- United States
- Prior art keywords
- focal spot
- liob
- recited
- focal
- distance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F9/00825—Methods or devices for eye surgery using laser for photodisruption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
- A61F2009/00872—Cornea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00897—Scanning mechanisms or algorithms
Definitions
- the present invention pertains generally to systems and methods for creating spot patterns for ophthalmic refractive laser surgery. More particularly, the present invention pertains to systems and methods which minimize the residual effects from laser induced optical breakdown (LIOB) at earlier laser focal points, on LIOB at subsequent laser focal points.
- LIOB laser induced optical breakdown
- the present invention is particularly, but not exclusively, useful for systems and methods wherein LIOB at adjacent focal points in the stroma (transparent material) is performed in accordance with a predetermined spatial and temporal separation.
- LIOB Laser Induced Optical Breakdown
- tissue being ablated may be subjected to several different phenomena.
- tissue that is peripheral to the ablated tissue is subject to adverse side effects, such as tearing (mechanical damage) and scorching (thermal damage).
- adverse side effects such as tearing (mechanical damage) and scorching (thermal damage).
- the pulse energy density must be above the tissue threshold in order for LIOB to occur.
- Focal Spot Size 1-10 ⁇ m diameter
- LIOB will still affect stromal tissue in at least three other different, identifiable ways. These are: 1) plasma formation; 2) shock wave generation; and 3) cavitation bubbles. Schematically, these three phenomena are shown in FIG. 1 of the drawings.
- a cavitation bubble 14 may be considered as continuing through two decay periods. Specifically, the decay of the bubble 14 experiences a first relaxation rate of approximately 10 microns per second (10 ⁇ m/sec) during a first decay period, of time “ ⁇ ”. During “ ⁇ ” the bubble 14 decays to a diameter “d 3 ” which is less than “d 2 ” but greater than “d 1 ” (d 1 ⁇ d 2 >d 3 , with d 3 >d 1 ). Typically, the period “ ⁇ ” is in the range of about 1-1000 ⁇ s and depends on a number of factors including pulse energy density. Thereafter, during a second decay period, the bubble 14 fully dissipates from the diameter “d 3 ” in about 15 to 30 minutes at a second relaxation rate of approximately half a micron per minute (0.5 ⁇ m/min).
- an object of the present invention to provide a system and method for performing laser induced optical breakdown (LIOB) in a substantially transparent material (i.e. the cornea of an eye) wherein a predetermined time period “ ⁇ ” is interposed between adjacent laser focal spots in a spot pattern.
- Another object of the present invention is to provide a system and method for performing laser induced optical breakdown (LIOB) in a substantially transparent material (i.e. the cornea of an eye) wherein a pattern of successive focal spots are both spatially and temporally separated from each other.
- Yet another object of the present invention is to provide a system and method for performing laser induced optical breakdown (LIOB) in a substantially transparent material (i.e.
- Still another object of the present invention is to provide a system and method for performing laser induced optical breakdown (LIOB) in a substantially transparent material (i.e. the cornea of an eye) which is easy to use, relatively simple to manufacture, and comparatively cost effective.
- LIOB laser induced optical breakdown
- a method and a system are presented for performing laser induced optical breakdown (LIOB) in a substantially transparent material, such as the cornea of an eye.
- the method includes a first step of calculating a pattern for a succession of laser focal spots in the material. Using this pattern, a surgical procedure is then performed wherein LIOB occurs at each focal spot in the pattern, in a volume of material having a diameter “d 1 ”.
- the LIOB at each focal spot results in the generation of a cavitation bubble that expands to a maximum diameter “d 2 ”.
- the diameter of the temporal cavitation bubble “d 2 ” will increase to at least twice the diameter of the focal spot “d 1 ”. It then collapses back toward the volume of the focal spot within a decay time “ ⁇ ” to a substantially stationary diameter “d 3 ”, with (d 1 ⁇ d 3 ⁇ d 2 ).
- the actual procedure begins by inducing LIOB at a first focal spot.
- the procedure then continues by inducing LIOB at a plurality of interim focal spots within a time period “ ⁇ ”.
- each of the interim spots is located at a distance greater than “d 2 ” from every other interim focal spot that is generated within the time period of “ ⁇ ”.
- a second focal spot in the pattern can then be generated at a distance “d 3 ” from the first focal spot.
- This process is then continued, with the second focal spot becoming a first focal spot.
- Another plurality of interim focal spots can then be generated within another time period “ ⁇ ”.
- each focal spot is generated in the pattern, it must be separated by at least the distance “d 2 ” from every other focal spot that was generated within the immediately preceding time period “ ⁇ ”.
- the distance “d 1 ” will be in a range of about 1 to 10 microns, and the distance “d 2 ” will be approximately equal to 2d 1 (d 2 ⁇ 2d 1 ). Further, the time period “ ⁇ ” will be typically less than approximately two microseconds ( ⁇ 2 ⁇ s). Also, as contemplated for the present invention, LIOB will be induced by a laser pulse which has a duration in a range of 1-1000 fs, an energy density in the range of 1-10 J/cm 2 , and a focal spot diameter of about 1-10 microns.
- FIG. 1 is a representation of the spatial relationships between the ablated tissue, shock wave, and cavitation bubble that result from LIOB;
- FIG. 2 is a graph showing the temporal decay of a typical cavitation bubble
- FIG. 3 is a schematic view of an operational laser beam as used for the present invention.
- FIG. 4 is a pattern sequence for the spatial and temporal separation of laser beam focal spots in accordance with the present invention.
- FIG. 5 is a time line for implementation of the sequence pattern shown in FIG. 4 ;
- FIG. 6 is a schematic view of a spiral pattern of focal spots.
- a laser system 16 is used to focus a laser beam 18 into a transparent material 20 , such as the stroma of an eye.
- the laser beam 18 is focused to a succession of focal spots 22 in the transparent material 20 , of which the focal spots 22 a - c are only exemplary.
- the succession of focal spots 22 are maneuvered to create a pattern 24 within the material 20 .
- the pattern 24 may be of any form or design well known in the pertinent art, such as a line, a curve, or a spiral.
- the focal spots 22 in pattern 24 are created by a laser beam 18 which includes a train of laser pulses that have a pulse repetition rate in the multi KHz region (i.e. around 10 KHz or more).
- each pulse in the train preferably has the following characteristics: 1) a pulse length (duration) in a range of 1-1000 femtoseconds; an energy density of 1-10 J/cm 2 ; and a focal spot size in a range of 1-10 ⁇ m diameter.
- a laser pulse having these parameters will induce LIOB in a tissue volume 12 of the material 20 that has a diameter “d 1 ”.
- This LIOB is then followed by the creation of a cavitation bubble 14 (see FIG. 1 ) that will have a diameter “d 2 ”.
- a procedure in accordance with the present invention starts at time “ ⁇ 0 ” (see FIG. 5 ) and at a predetermined location 26 in the material 20 .
- the procedure begins by focusing the laser beam 18 to induce LIOB with a focal spot 22 at the location 26 .
- the laser beam 18 is maneuvered on the move line 28 [x 1 ( ⁇ 1 )], through a distance “x 1 ” to a location 30 in the material 20 .
- the laser beam 18 is again focused to induce LIOB with another focal spot 22 at the location 30 .
- the laser beam 18 is maneuvered on the move line 32 [x 2 ( ⁇ 2 )], through a distance “x 2 ” to a location 34 in the material 20 .
- the laser beam 18 is focused at the location 34 to induce LIOB with another focal spot 22 .
- the move line 36 [x 3 ( ⁇ 3 )] in FIG. 4 indicates that the next LIOB occurs at a location 38 and, finally, the move line 40 [x 4 ( ⁇ )] shows that at the end of a time period “ ⁇ ”, LIOB occurs at the location 42 .
- each of the distances “x 1 ”, “x 2 ”, “x 3 ”, and “x 4 ”, though not necessarily equal to each other, are each greater than the distance “d 2 ”.
- the locations 30 , 34 , 38 and 42 are separated by more than the distance “d 2 ” from the locations of all of the earlier focal spots 22 that were created within the immediately preceding time period “ ⁇ ”.
- LIOB at the location 42 at the time “ ⁇ ”, is within a distance “d 3 ” from the location 26 .
- this juxtaposition of the locations 26 and 42 is possible because a time period “ ⁇ ” separates the inducement of LIOB at the respective locations 26 and 42 .
- ⁇ separates the inducement of LIOB at the respective locations 26 and 42 .
- five different locations have been discussed. It is to be appreciated, however, the present invention envisions LIOB at many more, or fewer, such locations within a time period “ ⁇ ”.
- each focal spot 22 is separated from every other focal spot 22 that is created within each time period “ ⁇ ”, by a distance greater than “d 2 ”.
- a first focal spot 22 is created, after the expiration of a time period “ ⁇ ”, a second focal spot 22 may be located within a distance “d 3 ” from the first focal spot 22 .
- a pattern 24 of focal spots 22 can be created using an “n” number of time periods “ ⁇ ”.
- the present methods are illustrated in an application in which a spiral pattern of LIOB focal spots is employed.
- the procedure begins at time “ ⁇ 0 ” (see FIG. 5 ) and at a predetermined location 44 in the material 20 ′.
- the procedure begins by focusing the laser beam 18 (see FIG. 3 ) to induce LIOB with a focal spot 22 at the location 44 .
- the laser beam 18 is rotated about axis 46 and in the direction of arrow 47 to a location 48 in the material 20 ′.
- the laser beam 18 is again focused to induce LIOB with another focal spot 22 at the location 48 .
- the distances between locations 44 , 48 , 50 , 52 and 54 are each greater than the distance “d 2 ”. Additionally, it is to be noted that the locations 44 , 48 , 50 , 52 and 54 are separated by more than the distance “d 2 ” from the locations of all of the earlier focal spots 22 that were created within the immediately preceding time period “ ⁇ ”. At or after the time “ ⁇ ”, LIOB can be induced at the location 56 , which is within a distance “d 3 ” from the location 44 , as shown. As contemplated by the present invention, this juxtaposition of the locations 44 and 56 is possible because a time period “ ⁇ ” separates the inducement of LIOB at the respective locations 44 and 56 . This process can then be continued until LIOB is induced at each location in the spiral pattern.
Abstract
Description
- The present invention pertains generally to systems and methods for creating spot patterns for ophthalmic refractive laser surgery. More particularly, the present invention pertains to systems and methods which minimize the residual effects from laser induced optical breakdown (LIOB) at earlier laser focal points, on LIOB at subsequent laser focal points. The present invention is particularly, but not exclusively, useful for systems and methods wherein LIOB at adjacent focal points in the stroma (transparent material) is performed in accordance with a predetermined spatial and temporal separation.
- During an ophthalmic laser surgical procedure, wherein stromal tissue within the cornea is ablated, the ablation is caused by an effect known as Laser Induced Optical Breakdown (LIOB). Typically, LIOB in the stroma is accomplished using pulsed laser beams that may have pulse repetition rates as high as 10 KHz. In detail, the LIOB effect of successive individual laser pulses is cumulative. Each individual laser pulse, however, can be considered separately.
- For an individual laser pulse, it happens during LIOB that the tissue being ablated may be subjected to several different phenomena. For one, tissue that is peripheral to the ablated tissue is subject to adverse side effects, such as tearing (mechanical damage) and scorching (thermal damage). It is known, however, that these particular adverse side effects can be avoided if the pulse energy density is minimized. On the other hand, the pulse energy density must be above the tissue threshold in order for LIOB to occur. With these countervailing considerations in mind, it has been determined that a laser pulse having the following characteristics can cause LIOB in stromal tissue, while avoiding adverse mechanical or thermal side effects on peripheral tissue.
- Laser Pulse
- Pulse Length (duration): 1-1000 femtoseconds
- Energy Density: 1-10 J/cm2
- Focal Spot Size: 1-10 μm diameter
- Pulse Repetition Rate: multi KHz
- Despite the adverse, but avoidable, side effects on peripheral tissue noted above, LIOB will still affect stromal tissue in at least three other different, identifiable ways. These are: 1) plasma formation; 2) shock wave generation; and 3) cavitation bubbles. Schematically, these three phenomena are shown in
FIG. 1 of the drawings. - Referring for the moment to
FIG. 1 in the drawings, the consequences of LIOB caused by a single laser pulse are illustrated in a spatial context. It is to be appreciated, however, these consequences also have a temporal context. First, a micro plasma is formed from tissue located within the focal spot of the laser pulse. Specifically, this plasma results from the evaporation ofcorneal tissue 10 in atissue volume 12 that has a diameter “d1” in the range of around 1-10 microns (d1=1-10 μm). The formation of this plasma is then followed by a shock wave that radiates through thetissue 10. Typically, the shock wave extends from the center ofvolume 12 through a radius “r” that is approximately twenty microns (r≅20 μm). The shock wave, however, decays within a few nanoseconds. Nevertheless, despite its relatively short duration, the shockwave effect should be kept as small as possible by using pulse energies that are not too far above the threshold for LIOB. - Perhaps, the most pronounced adverse effect from LIOB at relatively low pulse energies is the creation of a
cavitation bubble 14. Stated differently, at relatively low pulse energies there is typically no mechanical or thermal damage to peripheral tissue. Instead, a laser pulse having the parameters set forth above will induce LIOB that immediately results in a cavitation bubble 14 (seeFIG. 1 ). There it will be seen that thebubble 14 has a diameter “d2” that will generally be greater than about twice the diameter “d1” of the tissue volume 12 (d2≧2d1). Although thecavitation bubble 14 will eventually decay, as generally indicated inFIG. 2 , it has a time dependence that should be accounted for (N.B.FIG. 2 is only exemplary). In particular,FIG. 2 indicates the temporal influence of acavitation bubble 14 may be considered as continuing through two decay periods. Specifically, the decay of thebubble 14 experiences a first relaxation rate of approximately 10 microns per second (10 μm/sec) during a first decay period, of time “τ”. During “τ” thebubble 14 decays to a diameter “d3” which is less than “d2” but greater than “d1” (d1<d2>d3, with d3>d1). Typically, the period “τ” is in the range of about 1-1000 μs and depends on a number of factors including pulse energy density. Thereafter, during a second decay period, thebubble 14 fully dissipates from the diameter “d3” in about 15 to 30 minutes at a second relaxation rate of approximately half a micron per minute (0.5 μm/min). - In light of the above, it is an object of the present invention to provide a system and method for performing laser induced optical breakdown (LIOB) in a substantially transparent material (i.e. the cornea of an eye) wherein a predetermined time period “τ” is interposed between adjacent laser focal spots in a spot pattern. Another object of the present invention is to provide a system and method for performing laser induced optical breakdown (LIOB) in a substantially transparent material (i.e. the cornea of an eye) wherein a pattern of successive focal spots are both spatially and temporally separated from each other. Yet another object of the present invention is to provide a system and method for performing laser induced optical breakdown (LIOB) in a substantially transparent material (i.e. the cornea of an eye) wherein LIOB is induced at a location where the residual influence of earlier LIOB is effectively avoided. Still another object of the present invention is to provide a system and method for performing laser induced optical breakdown (LIOB) in a substantially transparent material (i.e. the cornea of an eye) which is easy to use, relatively simple to manufacture, and comparatively cost effective.
- In accordance with the present invention, a method and a system are presented for performing laser induced optical breakdown (LIOB) in a substantially transparent material, such as the cornea of an eye. Specifically, the method includes a first step of calculating a pattern for a succession of laser focal spots in the material. Using this pattern, a surgical procedure is then performed wherein LIOB occurs at each focal spot in the pattern, in a volume of material having a diameter “d1”. Inherently, the LIOB at each focal spot results in the generation of a cavitation bubble that expands to a maximum diameter “d2”. In this process, however, the diameter of the temporal cavitation bubble “d2” will increase to at least twice the diameter of the focal spot “d1”. It then collapses back toward the volume of the focal spot within a decay time “τ” to a substantially stationary diameter “d3”, with (d1≦d3≦d2).
- With the above in mind, once a pattern for LIOB has been determined, the actual procedure begins by inducing LIOB at a first focal spot. The procedure then continues by inducing LIOB at a plurality of interim focal spots within a time period “τ”. Importantly, each of the interim spots is located at a distance greater than “d2” from every other interim focal spot that is generated within the time period of “τ”. At the end of the time period “τ”, a second focal spot in the pattern can then be generated at a distance “d3” from the first focal spot. This process is then continued, with the second focal spot becoming a first focal spot. Another plurality of interim focal spots can then be generated within another time period “τ”. Importantly, as each focal spot is generated in the pattern, it must be separated by at least the distance “d2” from every other focal spot that was generated within the immediately preceding time period “τ”.
- As contemplated for the present invention, the distance “d1” will be in a range of about 1 to 10 microns, and the distance “d2” will be approximately equal to 2d1 (d2≅2d1). Further, the time period “τ” will be typically less than approximately two microseconds (τ≅2 μs). Also, as contemplated for the present invention, LIOB will be induced by a laser pulse which has a duration in a range of 1-1000 fs, an energy density in the range of 1-10 J/cm2, and a focal spot diameter of about 1-10 microns.
- The novel features of this invention, as well as the invention itself, both as to its structure and its operation, will be best understood from the accompanying drawings, taken in conjunction with the accompanying description, in which similar reference characters refer to similar parts, and in which:
-
FIG. 1 is a representation of the spatial relationships between the ablated tissue, shock wave, and cavitation bubble that result from LIOB; -
FIG. 2 is a graph showing the temporal decay of a typical cavitation bubble; -
FIG. 3 is a schematic view of an operational laser beam as used for the present invention; -
FIG. 4 is a pattern sequence for the spatial and temporal separation of laser beam focal spots in accordance with the present invention; -
FIG. 5 is a time line for implementation of the sequence pattern shown inFIG. 4 ; and -
FIG. 6 is a schematic view of a spiral pattern of focal spots. - Referring to
FIG. 3 , an environment for the present invention is shown wherein alaser system 16 is used to focus alaser beam 18 into atransparent material 20, such as the stroma of an eye. As indicated, thelaser beam 18 is focused to a succession of focal spots 22 in thetransparent material 20, of which the focal spots 22 a-c are only exemplary. Further, as also indicated inFIG. 3 , the succession of focal spots 22 are maneuvered to create apattern 24 within thematerial 20. For purposes of the present invention, thepattern 24 may be of any form or design well known in the pertinent art, such as a line, a curve, or a spiral. - Preferably, the focal spots 22 in
pattern 24 are created by alaser beam 18 which includes a train of laser pulses that have a pulse repetition rate in the multi KHz region (i.e. around 10 KHz or more). Further, each pulse in the train preferably has the following characteristics: 1) a pulse length (duration) in a range of 1-1000 femtoseconds; an energy density of 1-10 J/cm2; and a focal spot size in a range of 1-10 μm diameter. As stated above, a laser pulse having these parameters will induce LIOB in atissue volume 12 of the material 20 that has a diameter “d1”. This LIOB is then followed by the creation of a cavitation bubble 14 (seeFIG. 1 ) that will have a diameter “d2”. Inherently, it will happen that “d2” is more than twice the size of “d1” (d2≧2d1). As noted above, during a procedure as envisioned by the present invention, the temporal influence of eachcavitation bubble 14 will continue for a time period “τ” that may be several microseconds in duration. During this time period “τ”, thebubble 14 will collapse to a substantially stationary diameter “d3”, with (d1≦d3≦d2). - The operation of the present invention will, perhaps, be best appreciated with reference to
FIG. 4 . There it will be seen that a procedure in accordance with the present invention starts at time “τ0” (seeFIG. 5 ) and at apredetermined location 26 in thematerial 20. Specifically, the procedure begins by focusing thelaser beam 18 to induce LIOB with a focal spot 22 at thelocation 26. Then, during a time segment “Δτ” (τ0+Δτ=τ1), thelaser beam 18 is maneuvered on the move line 28 [x1(τ1)], through a distance “x1” to alocation 30 in thematerial 20. Thelaser beam 18 is again focused to induce LIOB with another focal spot 22 at thelocation 30. This occurs at time “τ1” (seeFIG. 5 ). It is an important aspect of the present invention that the distance “x1” is greater than the diameter “d2” of thecavitation bubble 14 that was created atlocation 26. Subsequently, during another time segment “Δτ” (τ0+2Δτ=τ1+Δτ=τ2), thelaser beam 18 is maneuvered on the move line 32 [x2(τ2)], through a distance “x2” to alocation 34 in thematerial 20. At time “τ2” thelaser beam 18 is focused at thelocation 34 to induce LIOB with another focal spot 22. Similarly, the move line 36 [x3(τ3)] inFIG. 4 indicates that the next LIOB occurs at alocation 38 and, finally, the move line 40 [x4(τ)] shows that at the end of a time period “τ”, LIOB occurs at thelocation 42. - In the sequence of focal spots 22 just discussed, each of the distances “x1”, “x2”, “x3”, and “x4”, though not necessarily equal to each other, are each greater than the distance “d2”. Additionally, it is to be noted that the
locations location 42, at the time “τ”, is within a distance “d3” from thelocation 26. As contemplated by the present invention, this juxtaposition of thelocations respective locations - In overview, several important aspects of the present invention will be appreciated by reference to
FIG. 4 . First, each focal spot 22 is separated from every other focal spot 22 that is created within each time period “τ”, by a distance greater than “d2”. Once a first focal spot 22 is created, after the expiration of a time period “τ”, a second focal spot 22 may be located within a distance “d3” from the first focal spot 22. Finally, apattern 24 of focal spots 22 can be created using an “n” number of time periods “τ”. - With cross-reference to
FIGS. 5 and 6 , the present methods are illustrated in an application in which a spiral pattern of LIOB focal spots is employed. Specifically, the procedure begins at time “τ0” (seeFIG. 5 ) and at apredetermined location 44 in the material 20′. Specifically, the procedure begins by focusing the laser beam 18 (seeFIG. 3 ) to induce LIOB with a focal spot 22 at thelocation 44. Then, during a time segment “Δτ” (τ0+Δτ=τ1), thelaser beam 18 is rotated aboutaxis 46 and in the direction ofarrow 47 to alocation 48 in the material 20′. Thelaser beam 18 is again focused to induce LIOB with another focal spot 22 at thelocation 48. This occurs at time “τ1” (seeFIG. 5 ). It is an important aspect of the present invention that the distance betweenlocation 44 andlocation 48 is greater than the diameter “d2” of thecavitation bubble 14 that was created atlocation 44. Subsequently, during another time segment “Δτ” (τ0+2Δτ=τ1+Δτ=τ2), thelaser beam 18 is rotated to alocation 50 in the material 20′. At time “τ2” thelaser beam 18 is focused at thelocation 50 to induce LIOB with another focal spot 22. This process continues with successive LIOB inducements atlocation 52 andlocation 54. In this sequence of focal spots 22 the distances betweenlocations locations location 56, which is within a distance “d3” from thelocation 44, as shown. As contemplated by the present invention, this juxtaposition of thelocations respective locations - While the particular Time-Resolved Scanning Patterns for Intrastromal Surgery as herein shown and disclosed in detail is fully capable of obtaining the objects and providing the advantages herein before stated, it is to be understood that it is merely illustrative of the presently preferred embodiments of the invention and that no limitations are intended to the details of construction or design herein shown other than as described in the appended claims.
Claims (20)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/978,613 US7717905B2 (en) | 2004-11-01 | 2004-11-01 | Time-resolved scanning patterns for intrastromal surgery |
PCT/IB2005/002883 WO2006048707A1 (en) | 2004-11-01 | 2005-09-28 | Time-resolved scanning patterns for intrastromal surgery |
JP2007538526A JP4833992B2 (en) | 2004-11-01 | 2005-09-28 | Time-resolved scanning pattern for parenchymal surgery |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/978,613 US7717905B2 (en) | 2004-11-01 | 2004-11-01 | Time-resolved scanning patterns for intrastromal surgery |
Publications (2)
Publication Number | Publication Date |
---|---|
US20060095023A1 true US20060095023A1 (en) | 2006-05-04 |
US7717905B2 US7717905B2 (en) | 2010-05-18 |
Family
ID=35788597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/978,613 Active 2028-11-14 US7717905B2 (en) | 2004-11-01 | 2004-11-01 | Time-resolved scanning patterns for intrastromal surgery |
Country Status (3)
Country | Link |
---|---|
US (1) | US7717905B2 (en) |
JP (1) | JP4833992B2 (en) |
WO (1) | WO2006048707A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1977725A1 (en) * | 2007-04-04 | 2008-10-08 | WaveLight AG | Device for processing material, in particular refractive eye surgery |
US20100249762A1 (en) * | 2007-12-17 | 2010-09-30 | Bille Josef F | System for Performing Intrastromal Refractive Surgery |
US20130310728A1 (en) * | 2012-05-16 | 2013-11-21 | Theo Seiler | Device for dissecting an eye for the introduction of photosensitizer and method of refractive surgery |
US20140066909A1 (en) * | 2012-09-06 | 2014-03-06 | Dr. Jackson Colemann | Device and procedure to treat presbyopia |
CN104487029A (en) * | 2012-08-28 | 2015-04-01 | 视乐有限公司 | Scanning methods and systems to reduce opaque bubble layers |
WO2017063673A1 (en) * | 2015-10-13 | 2017-04-20 | Novartis Ag | System and method for reducing post-surgical rainbow effect |
CN111479536A (en) * | 2017-10-30 | 2020-07-31 | 罗维阿克有限公司 | Device for producing an aperture stop in an eye |
Citations (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3769963A (en) * | 1972-03-31 | 1973-11-06 | L Goldman | Instrument for performing laser micro-surgery and diagnostic transillumination of living human tissue |
US4391275A (en) * | 1979-11-28 | 1983-07-05 | Lasag Ag | Method for the surgical treatment of the eye |
US4665913A (en) * | 1983-11-17 | 1987-05-19 | Lri L.P. | Method for ophthalmological surgery |
US4669466A (en) * | 1985-01-16 | 1987-06-02 | Lri L.P. | Method and apparatus for analysis and correction of abnormal refractive errors of the eye |
US4732148A (en) * | 1983-11-17 | 1988-03-22 | Lri L.P. | Method for performing ophthalmic laser surgery |
US4770172A (en) * | 1983-11-17 | 1988-09-13 | Lri L.P. | Method of laser-sculpture of the optically used portion of the cornea |
US4773414A (en) * | 1983-11-17 | 1988-09-27 | Lri L.P. | Method of laser-sculpture of the optically used portion of the cornea |
US4941093A (en) * | 1985-09-12 | 1990-07-10 | Summit Technology, Inc. | Surface erosion using lasers |
US4988348A (en) * | 1989-05-26 | 1991-01-29 | Intelligent Surgical Lasers, Inc. | Method for reshaping the cornea |
US5549632A (en) * | 1992-10-26 | 1996-08-27 | Novatec Laser Systems, Inc. | Method and apparatus for ophthalmic surgery |
US5984916A (en) * | 1993-04-20 | 1999-11-16 | Lai; Shui T. | Ophthalmic surgical laser and method |
US5993438A (en) * | 1993-11-12 | 1999-11-30 | Escalon Medical Corporation | Intrastromal photorefractive keratectomy |
US6010497A (en) * | 1998-01-07 | 2000-01-04 | Lasersight Technologies, Inc. | Method and apparatus for controlling scanning of an ablating laser beam |
US6231566B1 (en) * | 1998-08-12 | 2001-05-15 | Katana Research, Inc. | Method for scanning a pulsed laser beam for surface ablation |
US6322556B1 (en) * | 1991-10-30 | 2001-11-27 | Arlene E. Gwon | Method of laser photoablation of lenticular tissue for the correction of vision problems |
US6325792B1 (en) * | 1991-11-06 | 2001-12-04 | Casimir A. Swinger | Ophthalmic surgical laser and method |
US6610050B2 (en) * | 2001-07-27 | 2003-08-26 | 20/10 Perfect Vision, Optische Geraete Gmbh | Laser beam delivery system with multiple focal points |
US6610051B2 (en) * | 2001-10-12 | 2003-08-26 | 20/10 Perfect Vision Optische Geraete Gmbh | Device and method for performing refractive surgery |
US20030229339A1 (en) * | 2001-10-12 | 2003-12-11 | Josef Bille | Method and apparatus for intrastromal refractive surgery |
US20040039378A1 (en) * | 2000-06-01 | 2004-02-26 | Lin Charles P. | Selective photocoagulation |
US6805694B2 (en) * | 2001-05-18 | 2004-10-19 | Wavelight Laser Technologie Ag | Laser system for corneal grafting |
US20040243112A1 (en) * | 2003-06-02 | 2004-12-02 | Mark Bendett | Apparatus and method for ophthalmologic surgical procedures using a femtosecond fiber laser |
US20040243111A1 (en) * | 2003-06-02 | 2004-12-02 | Mark Bendett | Method and apparatus for precision working of material |
US20050165386A1 (en) * | 2002-03-23 | 2005-07-28 | Intralase Corp. | System and method for improved material processing using a laser beam |
US20060106371A1 (en) * | 2002-08-23 | 2006-05-18 | Dirk Muhlhoff | Device and method for meansuring an optical penetration in a tissue |
US20080208104A1 (en) * | 2005-04-18 | 2008-08-28 | Pantec Biosolutions Ag | Laser Microporator |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002522191A (en) * | 1998-08-12 | 2002-07-23 | ライ、ミン | Method for scanning pulsed laser beam for surface ablation |
DE10334109A1 (en) | 2003-07-25 | 2005-02-17 | Carl Zeiss Meditec Ag | Method of forming cuts in a transparent material such as the cornea of the eye in laser surgery using an arrangement of partial grids |
-
2004
- 2004-11-01 US US10/978,613 patent/US7717905B2/en active Active
-
2005
- 2005-09-28 WO PCT/IB2005/002883 patent/WO2006048707A1/en active Application Filing
- 2005-09-28 JP JP2007538526A patent/JP4833992B2/en not_active Expired - Fee Related
Patent Citations (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3769963A (en) * | 1972-03-31 | 1973-11-06 | L Goldman | Instrument for performing laser micro-surgery and diagnostic transillumination of living human tissue |
US4391275A (en) * | 1979-11-28 | 1983-07-05 | Lasag Ag | Method for the surgical treatment of the eye |
US4773414A (en) * | 1983-11-17 | 1988-09-27 | Lri L.P. | Method of laser-sculpture of the optically used portion of the cornea |
US4665913A (en) * | 1983-11-17 | 1987-05-19 | Lri L.P. | Method for ophthalmological surgery |
US4732148A (en) * | 1983-11-17 | 1988-03-22 | Lri L.P. | Method for performing ophthalmic laser surgery |
US4770172A (en) * | 1983-11-17 | 1988-09-13 | Lri L.P. | Method of laser-sculpture of the optically used portion of the cornea |
US4669466A (en) * | 1985-01-16 | 1987-06-02 | Lri L.P. | Method and apparatus for analysis and correction of abnormal refractive errors of the eye |
US4941093A (en) * | 1985-09-12 | 1990-07-10 | Summit Technology, Inc. | Surface erosion using lasers |
US4988348A (en) * | 1989-05-26 | 1991-01-29 | Intelligent Surgical Lasers, Inc. | Method for reshaping the cornea |
US6322556B1 (en) * | 1991-10-30 | 2001-11-27 | Arlene E. Gwon | Method of laser photoablation of lenticular tissue for the correction of vision problems |
US6325792B1 (en) * | 1991-11-06 | 2001-12-04 | Casimir A. Swinger | Ophthalmic surgical laser and method |
US5549632A (en) * | 1992-10-26 | 1996-08-27 | Novatec Laser Systems, Inc. | Method and apparatus for ophthalmic surgery |
US5984916A (en) * | 1993-04-20 | 1999-11-16 | Lai; Shui T. | Ophthalmic surgical laser and method |
US5993438A (en) * | 1993-11-12 | 1999-11-30 | Escalon Medical Corporation | Intrastromal photorefractive keratectomy |
US6010497A (en) * | 1998-01-07 | 2000-01-04 | Lasersight Technologies, Inc. | Method and apparatus for controlling scanning of an ablating laser beam |
US6231566B1 (en) * | 1998-08-12 | 2001-05-15 | Katana Research, Inc. | Method for scanning a pulsed laser beam for surface ablation |
US20040039378A1 (en) * | 2000-06-01 | 2004-02-26 | Lin Charles P. | Selective photocoagulation |
US6805694B2 (en) * | 2001-05-18 | 2004-10-19 | Wavelight Laser Technologie Ag | Laser system for corneal grafting |
US6610050B2 (en) * | 2001-07-27 | 2003-08-26 | 20/10 Perfect Vision, Optische Geraete Gmbh | Laser beam delivery system with multiple focal points |
US6610051B2 (en) * | 2001-10-12 | 2003-08-26 | 20/10 Perfect Vision Optische Geraete Gmbh | Device and method for performing refractive surgery |
US20030229339A1 (en) * | 2001-10-12 | 2003-12-11 | Josef Bille | Method and apparatus for intrastromal refractive surgery |
US20050165386A1 (en) * | 2002-03-23 | 2005-07-28 | Intralase Corp. | System and method for improved material processing using a laser beam |
US20060106371A1 (en) * | 2002-08-23 | 2006-05-18 | Dirk Muhlhoff | Device and method for meansuring an optical penetration in a tissue |
US20040243112A1 (en) * | 2003-06-02 | 2004-12-02 | Mark Bendett | Apparatus and method for ophthalmologic surgical procedures using a femtosecond fiber laser |
US20040243111A1 (en) * | 2003-06-02 | 2004-12-02 | Mark Bendett | Method and apparatus for precision working of material |
US7131968B2 (en) * | 2003-06-02 | 2006-11-07 | Carl Zeiss Meditec Ag | Apparatus and method for opthalmologic surgical procedures using a femtosecond fiber laser |
US20080208104A1 (en) * | 2005-04-18 | 2008-08-28 | Pantec Biosolutions Ag | Laser Microporator |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080249513A1 (en) * | 2007-04-04 | 2008-10-09 | Wavelight Ag | Apparatus for Treatment of Material, in Particular for Refractive Surgery |
WO2008122405A1 (en) * | 2007-04-04 | 2008-10-16 | Wavelight Ag | Device for material processing, particularly refractive eye surgery |
RU2471459C2 (en) * | 2007-04-04 | 2013-01-10 | Уэйвлайт Аг | Device for material processing, used in particular, in refractive surgery |
US8425498B2 (en) | 2007-04-04 | 2013-04-23 | Wavelight Ag | Apparatus for treatment of material, in particular for refractive surgery |
EP1977725A1 (en) * | 2007-04-04 | 2008-10-08 | WaveLight AG | Device for processing material, in particular refractive eye surgery |
US20100249762A1 (en) * | 2007-12-17 | 2010-09-30 | Bille Josef F | System for Performing Intrastromal Refractive Surgery |
US8409179B2 (en) * | 2007-12-17 | 2013-04-02 | Technolas Perfect Vision Gmbh | System for performing intrastromal refractive surgery |
US20130310728A1 (en) * | 2012-05-16 | 2013-11-21 | Theo Seiler | Device for dissecting an eye for the introduction of photosensitizer and method of refractive surgery |
US20150202084A1 (en) * | 2012-08-28 | 2015-07-23 | Wavelight Gmbh | Scanning methods and systems to reduce opaque bubble layers |
CN104487029A (en) * | 2012-08-28 | 2015-04-01 | 视乐有限公司 | Scanning methods and systems to reduce opaque bubble layers |
US20140066909A1 (en) * | 2012-09-06 | 2014-03-06 | Dr. Jackson Colemann | Device and procedure to treat presbyopia |
US10548771B2 (en) * | 2012-09-06 | 2020-02-04 | Carl Zeiss Meditec Ag | Device and procedure to treat presbyopia |
WO2017063673A1 (en) * | 2015-10-13 | 2017-04-20 | Novartis Ag | System and method for reducing post-surgical rainbow effect |
CN108135741A (en) * | 2015-10-13 | 2018-06-08 | 诺华股份有限公司 | For reducing the system and method for postoperative rainbow effect |
US10945884B2 (en) | 2015-10-13 | 2021-03-16 | Alcon Inc. | System and method for reducing post-surgical rainbow effect |
CN111479536A (en) * | 2017-10-30 | 2020-07-31 | 罗维阿克有限公司 | Device for producing an aperture stop in an eye |
US11406535B2 (en) * | 2017-10-30 | 2022-08-09 | Rowiak Gmbh | Device for creating an aperture in the eye |
Also Published As
Publication number | Publication date |
---|---|
JP2008517691A (en) | 2008-05-29 |
JP4833992B2 (en) | 2011-12-07 |
US7717905B2 (en) | 2010-05-18 |
WO2006048707A1 (en) | 2006-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lubatschowski et al. | Application of ultrashort laser pulses for intrastromal refractive surgery | |
EP2240108B1 (en) | Photodisruptive laser fragmentation of tissue | |
US9850159B2 (en) | High speed laser processing of transparent materials | |
US20180110655A1 (en) | Method and apparatus for precision working of material | |
Vogel et al. | Cavitation bubble dynamics and acoustic transient generation in ocular surgery with pulsed neodymium: YAG lasers | |
WO2006048707A1 (en) | Time-resolved scanning patterns for intrastromal surgery | |
US10918522B2 (en) | Photodisruption-based vitrectomy system | |
Lin et al. | High-speed photography of Er: YAG laser ablation in fluid. Implication for laser vitreous surgery. | |
EP3576695B1 (en) | Systems for laser ophthalmic surgery that provide for iris exposures below a predetermined exposure limit | |
EP2836175B1 (en) | Laser device and process for configuring such laser device | |
DK2789061T3 (en) | WASTE DEVICE AND METHOD FOR LASER PROCESSING A TARGET MATERIAL | |
US20200206034A1 (en) | Second pass femtosecond laser for incomplete laser full or partial thickness corneal incisions | |
Loesel et al. | Effect of reduction of laser pulse width from 100 ps to 20 fs on the plasma-mediated ablation of hard and soft tissue | |
WO2015184373A1 (en) | Treatment systems for vitreous floaters | |
CA2127029C (en) | Intrastromal photorefractive keratectomy | |
US20090299345A1 (en) | System and method for reshaping a cornea using a combination of liob and structural change procedures | |
US20200054397A1 (en) | Method of reducing stone fragments to dust during laser lithotripsy | |
US20210052423A1 (en) | Method for controlling an eye surgical laser and treatment device | |
Hoffman et al. | Photospallation: a new theory and mechanism for mid-infrared corneal ablations | |
RU2423958C1 (en) | Method of laser fragmentation of crystalline lens core | |
Schallen et al. | Rate‐dependent, nonlinear photoablation of ocular tissue at 308 nm | |
Rink et al. | Laser surgery at the micrometer scale: possibilities and limitations | |
Rink et al. | Laser surgery at the micrometer scale: possibilities and limitations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: 20/10 PERFECT VISION OPTISCHE GERAETE GMBH, GERMAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LOESEL, FRIEDER;KUHN, TOBIAS;REEL/FRAME:015485/0838 Effective date: 20041020 Owner name: 20/10 PERFECT VISION OPTISCHE GERAETE GMBH,GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LOESEL, FRIEDER;KUHN, TOBIAS;REEL/FRAME:015485/0838 Effective date: 20041020 |
|
AS | Assignment |
Owner name: 20/10 PERFECT VISION AG, GERMANY Free format text: CHANGE OF NAME;ASSIGNOR:20/10 PERFECT VISION OPTISCHE GERAETE GMBH;REEL/FRAME:023056/0389 Effective date: 20071108 Owner name: 20/10 PERFECT VISION AG,GERMANY Free format text: CHANGE OF NAME;ASSIGNOR:20/10 PERFECT VISION OPTISCHE GERAETE GMBH;REEL/FRAME:023056/0389 Effective date: 20071108 |
|
AS | Assignment |
Owner name: 20/10 PERFECT VISION OPERATIONS GMBH, GERMANY Free format text: CHANGE OF NAME;ASSIGNOR:20/10 PERFECT VISION AG;REEL/FRAME:023065/0012 Effective date: 20090428 Owner name: 20/10 PERFECT VISION OPERATIONS GMBH,GERMANY Free format text: CHANGE OF NAME;ASSIGNOR:20/10 PERFECT VISION AG;REEL/FRAME:023065/0012 Effective date: 20090428 |
|
AS | Assignment |
Owner name: TECHNOLAS PERFECT VISION GMBH, GERMANY Free format text: CHANGE OF NAME;ASSIGNOR:20/10 PERFECT VISION OPERATIONS GMBH;REEL/FRAME:023065/0970 Effective date: 20090428 Owner name: TECHNOLAS PERFECT VISION GMBH,GERMANY Free format text: CHANGE OF NAME;ASSIGNOR:20/10 PERFECT VISION OPERATIONS GMBH;REEL/FRAME:023065/0970 Effective date: 20090428 |
|
AS | Assignment |
Owner name: TECHNOLAS PERFECT VISION GMBH, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:20/10 PERFECT VISION AG;REEL/FRAME:023510/0024 Effective date: 20091106 Owner name: TECHNOLAS PERFECT VISION GMBH,GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:20/10 PERFECT VISION AG;REEL/FRAME:023510/0024 Effective date: 20091106 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
CC | Certificate of correction | ||
FEPP | Fee payment procedure |
Free format text: PAT HOLDER NO LONGER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: STOL); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
SULP | Surcharge for late payment | ||
AS | Assignment |
Owner name: BARCLAYS BANK PLC, AS COLLATERAL AGENT, NEW YORK Free format text: SECURITY AGREEMENT;ASSIGNORS:TECHNOLAS PERFECT VISION GMBH;DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH;REEL/FRAME:036400/0711 Effective date: 20150819 |
|
AS | Assignment |
Owner name: THE BANK OF NEW YORK MELLON, NEW YORK Free format text: SECURITY INTEREST;ASSIGNOR:TECHNOLAS PERFECT VISION GMBH;REEL/FRAME:043251/0910 Effective date: 20170717 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552) Year of fee payment: 8 |
|
AS | Assignment |
Owner name: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT, NEW YORK Free format text: SECURITY INTEREST;ASSIGNORS:ATON PHARMA, INC.;BAUSCH & LOMB INCORPORATED;BAUSCH & LOMB PHARMA HOLDINGS CORP.;AND OTHERS;REEL/FRAME:045444/0634 Effective date: 20180213 Owner name: BARCLAYS BANK PLC, AS COLLATERAL AGENT, NEW YORK Free format text: SECURITY INTEREST;ASSIGNORS:ATON PHARMA, INC.;BAUSCH & LOMB INCORPORATED;BAUSCH & LOMB PHARMA HOLDINGS CORP.;AND OTHERS;REEL/FRAME:045444/0299 Effective date: 20180213 Owner name: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT, Free format text: SECURITY INTEREST;ASSIGNORS:ATON PHARMA, INC.;BAUSCH & LOMB INCORPORATED;BAUSCH & LOMB PHARMA HOLDINGS CORP.;AND OTHERS;REEL/FRAME:045444/0634 Effective date: 20180213 |
|
AS | Assignment |
Owner name: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT, Free format text: INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNORS:BAUSCH HEALTH IRELAND LIMITED;BAUSCH HEALTH COMPANIES INC.;BAUSCH HEALTH, CANADA INC.;AND OTHERS;REEL/FRAME:049672/0652 Effective date: 20190701 Owner name: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT, NEW YORK Free format text: INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNORS:BAUSCH HEALTH IRELAND LIMITED;BAUSCH HEALTH COMPANIES INC.;BAUSCH HEALTH, CANADA INC.;AND OTHERS;REEL/FRAME:049672/0652 Effective date: 20190701 |
|
AS | Assignment |
Owner name: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT, NEW YORK Free format text: SECURITY INTEREST;ASSIGNORS:BAUSCH & LOMB IRELAND LIMITED;BAUSCH HEALTH COMPANIES INC.;DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH;AND OTHERS;REEL/FRAME:057821/0800 Effective date: 20211004 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 12 |
|
AS | Assignment |
Owner name: TECHNOLAS PERFECT VISION GMBH, GERMANY Free format text: RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 036400/0711);ASSIGNOR:BARCLAYS BANK PLC;REEL/FRAME:061775/0826 Effective date: 20221019 Owner name: BAUSCH & LOMB INCORPORATED, NEW YORK Free format text: RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 036400/0711);ASSIGNOR:BARCLAYS BANK PLC;REEL/FRAME:061775/0826 Effective date: 20221019 Owner name: LABORATOIRE CHAUVIN S.A.S., FRANCE Free format text: RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 045444/0299);ASSIGNOR:BARCLAYS BANK PLC;REEL/FRAME:061779/0001 Effective date: 20221019 Owner name: PF CONSUMER HEALTHCARE 1 LLC, DELAWARE Free format text: RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 045444/0299);ASSIGNOR:BARCLAYS BANK PLC;REEL/FRAME:061779/0001 Effective date: 20221019 Owner name: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, MARYLAND Free format text: RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 045444/0299);ASSIGNOR:BARCLAYS BANK PLC;REEL/FRAME:061779/0001 Effective date: 20221019 Owner name: TECHNOLAS PERFECT VISION GMBH, GERMANY Free format text: RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 045444/0299);ASSIGNOR:BARCLAYS BANK PLC;REEL/FRAME:061779/0001 Effective date: 20221019 Owner name: BAUSCH & LOMB INCORPORATED, NEW YORK Free format text: RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 045444/0299);ASSIGNOR:BARCLAYS BANK PLC;REEL/FRAME:061779/0001 Effective date: 20221019 |
|
AS | Assignment |
Owner name: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, MARYLAND Free format text: OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 045444/0634);ASSIGNOR:THE BANK OF NEW YORK MELLON;REEL/FRAME:061872/0295 Effective date: 20221018 Owner name: TECHNOLAS PERFECT VISION GMBH, GERMANY Free format text: OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 045444/0634);ASSIGNOR:THE BANK OF NEW YORK MELLON;REEL/FRAME:061872/0295 Effective date: 20221018 Owner name: LABORATOIRE CHAUVIN S.A.S., FRANCE Free format text: OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 045444/0634);ASSIGNOR:THE BANK OF NEW YORK MELLON;REEL/FRAME:061872/0295 Effective date: 20221018 Owner name: BAUSCH & LOMB INCORPORATED, NEW YORK Free format text: OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 045444/0634);ASSIGNOR:THE BANK OF NEW YORK MELLON;REEL/FRAME:061872/0295 Effective date: 20221018 Owner name: BAUSCH + LOMB IRELAND LIMITED, IRELAND Free format text: OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 057821/0800);ASSIGNOR:THE BANK OF NEW YORK MELLON;REEL/FRAME:061884/0514 Effective date: 20221018 Owner name: TECHNOLAS PERFECT VISION GMBH, GERMANY Free format text: OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 057821/0800);ASSIGNOR:THE BANK OF NEW YORK MELLON;REEL/FRAME:061884/0514 Effective date: 20221018 |